Correspondence - The Lancet

Heterologous prime-boost COVID-19 vaccination: initial reactogenicity data

25th June 2021

Read Letter

Paper - The Lancet

Safety and Immunogenicity Report from the Com-COV Study – a Single-Blind Randomised Non-Inferiority Trial Comparing Heterologous And Homologous Prime-Boost Schedules with An Adenoviral Vectored and mRNA COVID-19 Vaccine

25th June 2021

Read Paper